FdaApplication

BLA 103950

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSwedish Orphan Biovitrum AB (publ)
application_typeBLA
approval_date2001-11-14

Products (3)

ProductActive ingredientStrengthDosage form
KINERETANAKINRA18MIU/VIALVIAL;SUBCUTANEOUS
KINERETANAKINRA25MIU/VIALVIAL;SUBCUTANEOUS
KINERETANAKINRA100MG/0.67MLVIAL;SUBCUTANEOUS

3 products